The frequency of omentin Val109Asp polymorphism and the serum level of omentin in patients with Rheumatoid arthritis

Acta Medica Mediterranea

Volumn 29, Issue 3, 2013, Pages 521-526

  Yaykaşli, Küŗat Oǧuz ^a   Yaykaşli, Emine ^a   Ataoǧlu, Safinaz ^a   Özşahin, Mustafa ^a   Memişoǧullari, Ramazan ^a   Çelebi, Esra ^a   Uçgun, Taner ^a   Engin özcan, Muhammet ^a   Uslu, Mustafa ^a   Yüce, Hüseyin ^a  

^a DUZCE UNIVERSITY   (Turkey)

Author keywords

ELISA; Omentin; Polymorphism; Rheumatoid Artrit

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; OMENTIN; RHEUMATOID FACTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84886025837     PISSN: 03936384     EISSN: 22839720     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Poole CA. Articular cartilage chondrons:form, function and failure. J Anat. 1997; 191 (Pt 1):1-13.
2. James CB, Uhl TL. A review of articular cartilage pathology and the use of glucosamine sulfate. J Athl Train. 2001; 36(4):413-9.
3. Frisenda S, Perricone C, Valesini G. Cartilage as a target of autoimmunity:A thin layer. Autoimmun Rev 2013; 12(5):591-8.
4. Sayarlioglu M, Izmirli M, Uzun K, Alici S, Erkoç R. Rheumatoid arthritis and pulmonary carcinoid tumor. Eur J Gen Med 2005; 2(1):35-38.
5. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006; 11:529-43.
6. Turesson C. Extra-articular rheumatoid arthritis. Curr Opin Rheumatol 2013; 25(3):360-6.
7. Yazici S, Bulur S, Sözen SB, Çalik Y, Baki AE, Önder E, Özhan H, Yazici M, Ataoglu S. Evaluation of Lipid Parameters in Patients with Rheumatoid Arthritis. Konuralp Tip Dergisi [Konuralp Medical Journal] 2009; 1(1):2-6.
8. Kurkó J, Besenyei T, Laki J, Glant TT, Mikecz K, Szekanecz Z. Genetics of Rheumatoid Arthritis-A Comprehensive Review. Clin Rev Allergy Immunol. 2013 Jan 5. [Epub ahead of print]
9. Viatte S, Plant D, Raychaudhuri S. Genetics and epigenetics of rheumatoid arthritis. Nat Rev Rheumatol Nat Rev Rheumatol. 2013; 9(3):141-53.
10. Conde J, Scotece M, López V, Gómez R, Lago F, Pino J, Gómez-Reino JJ, Gualillo O. Adipokines:novel players in rheumatic diseases. Discov Med. 2013; 15(81): 73-83.
11. Scotece M, Conde J, Gómez R, López V, Lago F, Gómez-Reino JJ, Gualillo O. Beyond fat mass:exploring the role of adipokines in rheumatic diseases. Scientific World Journal 2011; 11:1932-47.
12. Yang RZ, Shuldiner AR, Gong DW. Cloning of omentin, a new adipokine from human omental fat tissue. NCBI nucleotide database, 2003; Accession Number: AY549722.
13. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, Gong DW. Identification of omentin as a novel depot-specific adipokine in human adipose tissue:possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006; 290:E1253-61.
14. Alcelik A, Tosun M, Ozlu MF, Eroglu M, Aktas G, Kemahli E, Savli H, Yazici M. Serum Levels of Omentin in End-Stage Renal Disease Patients. Kidney Blood Press Res 2012; 35(6):511-516.
15. Shibata R, Ouchi N, Kikuchi R, Takahashi R, Takeshita K, Kataoka Y, Ohashi K, Ikeda N, Kihara S, Murohara T. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 2011; 219:811-4.
16. Turan H, Karkucak M, Yakut T, Ozsahin M, Gurlevik Z, Yanik ME, et al. Does MBL2 codon 54 polymorphism play a role in the pathogenesis of psoriasis? Int J Dermatol. 2012 Nov 1. doi:10.1111/j.1365-4632.2012.5657.x.
17. Arslan UG, Ozmerdivenli R, Yaykasli KO, Oktay M, Erdem H, Soguktas H, Yamak N, Yaykasli E. Investigation of TIMP2 gene polymorphisms incidence in patients with breast cancer. Eur J Basic Med Sci 2013; 2(4):101-105.
18. Pfeil A, Oelzner P, Bornholdt K, Hansch A, Lehmann G, Renz DM, Wolf G, Bottcher J. Joint damage in rheumatoid arthritis:assessment of a new scoring method. Arthritis Res Ther 2013; 15(1):R27.
19. Nikolaus S, Bode C, Taal E, van de Laar MA. Fatigue and factors related to fatigue in rheumatoid arthritis:A systematic review. Arthritis Care Res (Hoboken). 2013 Jan 17. doi:10.1002/acr.21949. [Epub ahead of print].
20. Yaykasli KO, Oohashi T, Hirohata S, Hatipoglu OF, Inagawa K, Demircan K, Ninomiya Y. ADAMTS9 activation by interleukin 1 beta via NFATc1 in OUMS-27 chondrosarcoma cells and in human chondrocytes. Mol Cell Biochem. 2009; 323(1-2):69-79.
21. Sumer EU, Schaller S, Sondergaard BC, Tankó LB, Qvist P. Application of biomarkers in the clinical development of new drugs for chondroprotection in destructive joint diseases:a review. Biomarkers. 2006; 11(6): 485-506.
22. Vergunst CE, van de Sande MG, Lebre MC, Tak PP. The role of chemokines in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol. 2005; 34(6):415-25.
23. Boissier MC, Semerano L, Challal S, Saidenberg-Kermanac'h N, Falgarone G. Rheumatoid arthritis:from autoimmunity to synovitis and joint destruction. J Autoimmun. 2012; 39(3):222-8.
24. Gabay O, Berenbaum F. Adipokines in Arthritis:New Kids on the Block. Current Rheumatology Reviews 2009; 5:226-232.
25. Canoruc N, Kale E, Turhanoglu AD, Özmen S, Ogun C, Kaplan A. Plasma resistin and leptin in overweight and lean patients with rheumatoid arthritis. Turk J Med Sci 2009; 39(3):447-451.
26. Bao JP, Chen WP, Feng J, Hu PF, Shi ZL, Wu LD. Leptin plays a catabolic role on articular cartilage. Mol Biol Rep 2010; 37(7):3265-72.
27. Wislowska M, Rok M, Jaszczyk B, Stepien K, Cicha M. Serum leptin in rheumatoid arthritis. Rheumatol Int. 2007; 27(10):947-54.
28. Targonska-Stepniak B, Majdan M, Dryglewska M. Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity. Rheumatol Int 2008; 28(6):585-91.
29. Targonska-Stepniak B, Dryglewska M, Majdan M. Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis. Rheumatol Int 2010; 30(6): 731-7.
30. Chen X, Lu J, Bao J, Guo J, Shi J, Wang Y. Adiponectin:A biomarker for rheumatoid arthritis? Cytokine Growth Factor Rev 2013; 24(1):83-9.
31. Ebina K, Fukuhara A, Ando W, Hirao M, Koga T, Oshima K, Matsuda M, Maeda K, Nakamura T, Ochi T, Shimomura I, Yoshikawa H, Hashimoto J. Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction. Clin Rheumatol 2009; 28(4):445-51.
32. Ozgen M, Koca SS, Dagli N, Balin M, Ustundag B, Isik A. Serum adiponectin and vaspin levels in rheumatoid arthritis. Arch Med Res 2010; 41(6):457-63.
33. Stofkova A. Resistin and visfatin:regulators of insulin sensitivity, inflammation and immunity. Endocr Regul 2010; 44(1):25-36.
34. Senolt L, Housa D, Vernerová Z, Jirásek T, Svobodová R, Veigl D, Anderlová K, Müller-Ladner U, Pavelka K, Haluzík M. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 2007; 66(4):458-63.
35. Fadda SM, Gamal SM, Elsaid NY, Mohy AM. Resistin in inflammatory and degenerative rheumatologic diseases: Relationship between resistin and rheumatoid arthritis disease progression. Z Rheumatol 2013 Mar 9. [Epub ahead of print]
36. Zhang Z, Xing X, Hensley G, Chang LW, Liao W, Abu-Amer Y, Sandell LJ. Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization. Arthritis Rheum. 2010; 62(7):1993-2003.
37. Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gómez-Reino JJ, Gualillo O. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis. 2006; 65(9):1198-201.
38. Gosset M, Berenbaum F, Salvat C, Sautet A, Pigenet A, Tahiri K, Jacques C. Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes:possible influence on osteoarthritis. Arthritis Rheum 2008; 58(5):1399-409.
39. Bao JP, Chen WP, Wu LD. Visfatin:a potential therapeutic target for rheumatoid arthritis. J Int Med Res 2009; 37(6):1655-61.
40. Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, Shintani A, Pincus T, Stein CM. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 2009; 60(7):1906-14.
41. Senolt L, Polanská M, Filková M, Cerezo LA, Pavelka K, Gay S, Haluzík M, Vencovsky J. Vaspin and omentin:new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis 2010; 69(7):1410-1411.